Phosphorylated Insulin Like Growth Factor-I Receptor Expression and Its Clinico-Pathological Significance in Histologic Subtypes of Human Thyroid Cancer

被引:14
作者
Chakravarty, Geetika [1 ]
Santillan, Alfredo A. [2 ]
Galer, Chad [2 ]
Adams, Henry P. [3 ]
El-Naggar, Abdal K. [4 ]
Jasser, Samar A. [2 ]
Mohsin, Sayed [5 ]
Mondal, Debasis
Clayman, Gary L. [2 ,6 ,7 ]
Myers, Jeffrey N. [2 ,6 ]
机构
[1] Tulane Univ, Hlth Sci Ctr, Dept Pharmacol, Sch Med, New Orleans, LA 70112 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
[5] Riverside Methodist Grant Hosp, Columbus, OH 43214 USA
[6] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA
[7] Univ Texas MD Anderson Canc Ctr, Endocrine Ctr, Houston, TX 77030 USA
关键词
phospho-IGF-IR; phospho-insulin receptor; insulin like growth factor-I; thyroid carcinoma; tyrosine kinase receptor; prognostic factor; tissue array; Image Pro; AUTOCRINE LOOP; IGF-I; ANAPLASTIC TRANSFORMATION; CELL-PROLIFERATION; EPITHELIAL-CELLS; CARCINOMA; MITOGENESIS; ACTIVATION; SYSTEM; TUMORS;
D O I
10.3181/0809-RM-284
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Overexpression of insulin-like growth factor-I receptor (IGF-IR) is seen in a multitude of human thyroid cancers and correlates with poor prognosis. However, recent studies suggest that low phospho-IGF-IR (pIGF-IR) expression rather than its overexpression may be an indicator of poorly differentiated disease. No previous study has evaluated the expression of pIGF-IR to determine if activation or loss of expression of this receptor is associated with thyroid tumor progression. Accordingly, a quantitative immunohistochemical (IHC) method was used to evaluate the clinico-pathological significance of pIGF-IR expression in archival samples of human thyroid carcinomas. Quantitative analysis of pIGF-IR levels revealed a significant difference in the median index of pIGF-IR between different histological subtypes of thyroid cancer (P < 0.001). Specifically, the median pIGF-IR index of differentiated thyroid cancers was significantly higher than the median index of other poorly differentiated thyroid cancer (P < 0.001). This was further confirmed in individual tumor sections of thyroid carcinoma where anaplastic and differentiated components co-existed. No significant difference was noted in the pIGF-IR index of tumors grouped by size or stage but a trend towards lower mean pIGF-IR index was noted in older patients. Our data indicates that pIGF-IR is upregulated in a majority of follicular thyroid carcinomas, suggesting it may be a potential target for therapy for patients with this disease. In addition, since low pIGF-IR expression was found to correlate with aggressive human thyroid carcinoma, it also suggests that IGF-IR may not be needed for progression of anaplastic thyroid carcinoma possibly because other cell signaling pathways are activated, obviating the need for IGF-IR signaling. However, more mechanistic studies would be necessary to substantiate the possibility that pIGF-IR may be important for differentiation of thyroid tissues and is lost with disease progression. Exp Biol Med 234:372-386, 2009
引用
收藏
页码:372 / 386
页数:15
相关论文
共 46 条
[1]   INSULIN-LIKE GROWTH-FACTORS IN SHEEP THYROID-CELLS - ACTION, RECEPTORS AND PRODUCTION [J].
BACHRACH, LK ;
EGGO, MC ;
HINTZ, RL ;
BURROW, GN .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 154 (03) :861-867
[2]   Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insulin-like growth factor receptor in mammary tumor cells [J].
Balañá, ME ;
Labriola, L ;
Salatino, M ;
Movsichoff, F ;
Peters, G ;
Charreau, EH ;
Elizalde, PV .
ONCOGENE, 2001, 20 (01) :34-47
[3]  
BASERGA R, 1995, CANCER RES, V55, P249
[4]   The IGF-I receptor and cancer [J].
Baserga, R ;
Resnicoff, M ;
Dews, M .
ENDOCRINE, 1997, 7 (01) :99-102
[5]   The igf-1 receptor in cancer biology [J].
Baserga, R ;
Peruzzi, F ;
Reiss, K .
INTERNATIONAL JOURNAL OF CANCER, 2003, 107 (06) :873-877
[6]  
BERGMANN U, 1995, CANCER RES, V55, P2007
[7]   Intracellular transactivation of the insulin-like growth factor I receptor by an epidermal growth factor receptor [J].
Burgaud, JL ;
Baserga, R .
EXPERIMENTAL CELL RESEARCH, 1996, 223 (02) :412-419
[8]   Thyrotropin via cyclic AMP induces insulin receptor expression and insulin co-stimulation of growth and amplifies insulin and insulin-like growth factor signaling pathways in dog thyroid epithelial cells [J].
Burikhanov, R ;
Coulonval, K ;
Pirson, I ;
Lamy, F ;
Dumont, JE ;
Roger, PP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (46) :29400-29406
[9]   The IGF-I/IGF-I receptor pathway: Implications in the pathophysiology of thyroid cancer [J].
Ciampolillo, A ;
De Tullio, C ;
Giorgino, F .
CURRENT MEDICINAL CHEMISTRY, 2005, 12 (24) :2881-2891
[10]   Insulin-like growth factor-I is an important antiapoptotic factor for rat Leydig cells during postnatal development [J].
Colon, Eugenia ;
Zaman, Farasat ;
Axelson, Magnus ;
Larsson, Olle ;
Carlsson-Skwirut, Christine ;
Svechnikov, Konstantin V. ;
Soder, Olle .
ENDOCRINOLOGY, 2007, 148 (01) :128-139